日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phosphorylation Protects Oncogenic RAS from LZTR1-Mediated Degradation

磷酸化保护致癌RAS免受LZTR1介导的降解

Zhang, Lin; Bolomsky, Arnold; Al-Odat, Omar S; VanWinkle, Callie; Battle, Aaliyah; Chakraborty, Papiya; Holewinski, Ronald J; Andresson, Thorkell; Meng, Qingcai; Phelan, James D; Muppidi, Jagan; Young, Ryan M

IRF4 requires ARID1A to establish plasma cell identity in multiple myeloma

IRF4 需要 ARID1A 来确立多发性骨髓瘤中浆细胞的身份。

Arnold Bolomsky,Michele Ceribelli,Sebastian Scheich,Kristina Rinaldi,Da Wei Huang,Papiya Chakraborty,Lisette Pham,George W Wright,Tony Hsiao,Vivian Morris,Jaewoo Choi,James D Phelan,Ronald J Holewinski,Thorkell Andresson,Jan Wisniewski,Deanna Riley,Stefania Pittaluga,Elizabeth Hill,Craig J Thomas,Jagan Muppidi,Ryan M Young

Response to Bruton's tyrosine kinase inhibitors in aggressive lymphomas linked to chronic selective autophagy

布鲁顿酪氨酸激酶抑制剂对侵袭性淋巴瘤的疗效与慢性选择性自噬有关

James D Phelan ,Sebastian Scheich ,Jaewoo Choi ,George W Wright ,Björn Häupl ,Ryan M Young ,Sara A Rieke ,Martine Pape ,Yanlong Ji ,Henning Urlaub ,Arnold Bolomsky ,Carmen Doebele ,Alena Zindel ,Tanja Wotapek ,Monica Kasbekar ,Brett Collinge ,Da Wei Huang ,Zana A Coulibaly ,Vivian M Morris ,Xiaoxuan Zhuang ,Julius C Enssle ,Xin Yu ,Weihong Xu ,Yandan Yang ,Hong Zhao ,Zhuo Wang ,Andy D Tran ,Christopher J Shoemaker ,Galina Shevchenko ,Daniel J Hodson ,Arthur L Shaffer 3rd ,Louis M Staudt ,Thomas Oellerich

Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas

靶向N-连接糖基化治疗侵袭性淋巴瘤

Sebastian Scheich ,Jiji Chen ,Jiamin Liu ,Frank Schnütgen ,Julius C Enssle ,Michele Ceribelli ,Craig J Thomas ,Jaewoo Choi ,Vivian Morris ,Tony Hsiao ,Hang Nguyen ,Boya Wang ,Arnold Bolomsky ,James D Phelan ,Sean Corcoran ,Henning Urlaub ,Ryan M Young ,Björn Häupl ,George W Wright ,Da Wei Huang ,Yanlong Ji ,Xin Yu ,Weihong Xu ,Yandan Yang ,Hong Zhao ,Jagan Muppidi ,Kuan-Ting Pan ,Thomas Oellerich ,Louis M Staudt

Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma

致癌性RAS劫持氨基酸感应机制,在多发性骨髓瘤中异常激活mTORC1

Yandan Yang #,Arnold Bolomsky #,Thomas Oellerich #,Ping Chen #,Michele Ceribelli,Björn Häupl,George W Wright,James D Phelan,Da Wei Huang,James W Lord,Callie K Van Winkle,Xin Yu,Jan Wisniewski,James Q Wang,Frances A Tosto,Erin Beck,Kelli Wilson,Crystal McKnight,Jameson Travers,Carleen Klumpp-Thomas,Grace A Smith,Stefania Pittaluga,Irina Maric,Dickran Kazandjian,Craig J Thomas,Ryan M Young

Pathogenic signaling in multiple myeloma

多发性骨髓瘤中的致病信号传导

Bolomsky, Arnold; Young, Ryan M

Correction to: MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents

更正:MCL-1抑制剂,快速开发一类新型抗癌药物

Bolomsky, Arnold; Vogler, Meike; Köse, Murat Cem; Heckman, Caroline A; Ehx, Grégory; Ludwig, Heinz; Caers, Jo

Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma

使用 HIV 蛋白酶抑制剂奈非那韦治疗可确定膜脂质组成和流动性是晚期多发性骨髓瘤的治疗靶点

Lenka Besse #, Andrej Besse #, Sara C Stolze, Amin Sobh, Esther A Zaal, Alwin J van der Ham, Mario Ruiz, Santosh Phuyal, Lorina Büchler, Marc Sathianathan, Bogdan I Florea, Jan Borén, Marcus Ståhlman, Julia Huber, Arnold Bolomsky, Heinz Ludwig, J Thomas Hannich, Alex Loguinov, Bart Everts, Celia R B

Synergistic interaction between HDAC and MCL-1 inhibitors through downregulation of BCL-XL in multiple myeloma

HDAC 和 MCL-1 抑制剂通过下调 BCL-XL 在多发性骨髓瘤中发挥协同作用

Schneller, Anja; Zojer, Niklas; Bolomsky, Arnold; Ludwig, Heinz

Heterogeneous modulation of Bcl-2 family members and drug efflux mediate MCL-1 inhibitor resistance in multiple myeloma

Bcl-2家族成员的异质性调控和药物外排介导多发性骨髓瘤中的MCL-1抑制剂耐药性

Bolomsky, Arnold; Miettinen, Juho J; Malyutina, Alina; Besse, Andrej; Huber, Julia; Fellinger, Stefanie; Breid, Helene; Parsons, Alun; Klavins, Kristaps; Hannich, J Thomas; Kubicek, Stefan; Caers, Jo; Hübl, Wolfgang; Schreder, Martin; Zojer, Niklas; Driessen, Christoph; Tang, Jing; Besse, Lenka; Heckman, Caroline A; Ludwig, Heinz